不是，这个新药在做二期临试，不可能大规模使用

https://clinicaltrials.gov/ct2/show/NCT04747574

 

 

一期的三十名结果为

• EXO-CD24 is a medication delivered directly to the lungs, where it’ll help prevent the immune system dealing with COVID-19 from overreacting and causing complications.
• The drug is administered once a day for five minutes via inhalation. In Phase 1 trials, 29 out of 30 people suffering from moderate to severe COVID-19 recovered within 3-5 days, and all of them survived.

EXO-C24 isn’t an anti-viral that goes after the virus, looking to eliminate it. The immune system can do that on its own, and that’s why many people recover from COVID-19 even without treatment. This drug deals with the cytokine storm, preventing the overreaction from taking place.

https://bgr.com/2021/02/06/coronavirus-cure-exo-cd24-trial-israel/